Valuation: IRADIMED CORPORATION

Market Cap 1.2B 1.06B 983M 904M 1.69B 116B 1.73B 11.75B 4.58B 56.81B 4.51B 4.42B 197B P/E 2026 *
49.3x
P/E 2027 * 43.5x
Enterprise Value 1.2B 1.06B 983M 904M 1.69B 116B 1.73B 11.75B 4.58B 56.81B 4.51B 4.42B 197B EV / Sales 2026 *
13.2x
EV / Sales 2027 * 11.9x
Free-Float
64.8%
Yield 2026 *
-
Yield 2027 * -
1 day-0.33%
1 week-4.42%
Current month-2.21%
1 month+1.18%
3 months+5.24%
6 months-7.35%
Current year-3.94%
1 week 92.76
Extreme 92.765
98.46
1 month 90.83
Extreme 90.83
102.99
Current year 76.95
Extreme 76.95
107.9
1 year 55.11
Extreme 55.1093
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 2020-05-27
Director of Finance/CFO 64 2022-06-19
Chief Tech/Sci/R&D Officer - 2019-12-31
Director TitleAgeSince
Chairman 72 2020-06-15
Director/Board Member 70 2018-12-31
Director/Board Member 73 2013-12-31
Date Insider Type Main position Quantity % Market Cap.
6/20/26 Fiscal year

Chief Financial Officer

13,911 0.1088%
6/4/26 Sell

Director

-3,000 0.0235%
6/1/26 Sell

Chief Executive Officer

-2,500 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
-0.52%-4.42%+63.95%+106.02% 1.2B
+0.01%+4.45%-14.78%-16.59% 13.79B
+1.52%-8.34%+40.09%-8.60% 3.89B
-3.05%-2.34%-38.13%-60.52% 1.21B
+0.19%-2.78%-41.32%-47.39% 1.09B
+0.34%+2.35%-42.93% - 934M
+2.37%-14.11%+49.28%+79.71% 457M
-5.64%+2.03%+53.41% - 345M
-0.21%+0.88%-58.49%+234.80% 262M
-2.45%-8.64%+20.66%+38.25% 141M
Average -0.72%+0.00%+3.17%+40.71% 2.33B
Weighted average by Cap. +0.05%+2.14%-3.17%-7.09%

Financials

2026 *2027 *
Net sales 91.2M 80.21M 74.51M 68.53M 129M 8.83B 131M 891M 348M 4.31B 342M 335M 14.95B 101M 88.74M 82.44M 75.82M 142M 9.77B 145M 986M 385M 4.77B 379M 371M 16.53B
Net income 24.55M 21.59M 20.06M 18.45M 34.6M 2.38B 35.22M 240M 93.56M 1.16B 92.17M 90.17M 4.02B 27.8M 24.45M 22.71M 20.89M 39.18M 2.69B 39.88M 272M 106M 1.31B 104M 102M 4.56B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
26-07-23 US$93.45 -0.67% 59,516
26-07-22 US$94.08 -0.94% 91,871
26-07-21 US$94.97 -2.12% 126,070
26-07-20 US$97.03 0.00% 75,920
26-07-17 US$97.03 -0.76% 129,671
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
94.08USD
Average target price
118.00USD
Spread / Average Target
+25.43%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock